These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10661742)

  • 1. A new model for collaboration--making emergency contraceptives available in developing countries.
    Senanayake P
    Int J Gynaecol Obstet; 1999 Dec; 67 Suppl 2():S59-65; discussion S67. PubMed ID: 10661742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Public/private-sector collaboration in contraceptive research and development: summary and historical perspective.
    Spieler J
    Int J Gynaecol Obstet; 1999 Dec; 67 Suppl 2():S13-22. PubMed ID: 10661737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Introducing new contraceptives.
    Segal SJ; Coutinho E
    Draper Fund Rep; 1986 Dec; (15):27-32. PubMed ID: 12341234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The promise of public/private sector collaboration in the development of new contraceptives: the experience of CICCR.
    Harper MJ
    Int J Gynaecol Obstet; 1999 Dec; 67 Suppl 2():S23-30. PubMed ID: 10661738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Collaborative research and development on mifepristone in China to reduce unwanted pregnancies and recourse to abortion.
    Duncan GW
    Int J Gynaecol Obstet; 1999 Dec; 67 Suppl 2():S69-76. PubMed ID: 10661743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Children's Vaccine Initiative and vaccine supply: the role of the public sector.
    van Noort RB
    Vaccine; 1992; 10(13):909-10. PubMed ID: 1471410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Another view on Norplant: match method with users.
    Herndon N
    Netw Res Triangle Park N C; 1992 Oct; 13(2):24-6. PubMed ID: 12286081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pushing the frontiers of science: reflections on an Institute of Medicine study.
    Rosenfield A
    Int J Gynaecol Obstet; 1999 Dec; 67 Suppl 2():S93-9. PubMed ID: 10661746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The strategic approach to contraceptive introduction.
    Simmons R; Hall P; Díaz J; Díaz M; Fajans P; Satia J
    Stud Fam Plann; 1997 Jun; 28(2):79-94. PubMed ID: 9216029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applying a Total Market Lens: Increased IUD Service Delivery Through Complementary Public- and Private-Sector Interventions in 4 Countries.
    White JN; Corker J
    Glob Health Sci Pract; 2016 Aug; 4 Suppl 2(Suppl 2):S21-32. PubMed ID: 27540122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical care cost savings from adolescent contraceptive use.
    Trussell J; Koenig J; Stewart F; Darroch JE
    Fam Plann Perspect; 1997; 29(6):248-55, 295. PubMed ID: 9429869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Contraceptive development--the view from the U.S.A. in the mid 80s].
    Potts M; Siemens A; Burton N
    Contracept Fertil Sex (Paris); 1986 Mar; 14(3):247-51. PubMed ID: 12268061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Public-private partnerships advance contraceptive research and development.
    Harper MJ
    Contraception; 2008 Oct; 78(4 Suppl):S36-41. PubMed ID: 18847598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Some immediate results from the integration of family planning into health services and from contraceptive use].
    Butera B
    Imbonezamuryango; 1990 Aug; (18):14-21. PubMed ID: 12316569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional trends in the use of short-acting and long-acting contraception accessed through the private and public sectors.
    Ugaz JI; Chatterji M; Gribble JN; Mitchell S
    Int J Gynaecol Obstet; 2015 Aug; 130 Suppl 3():E3-7. PubMed ID: 26001703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vouchers in Fragile States: Reducing Barriers to Long-Acting Reversible Contraception in Yemen and Pakistan.
    Boddam-Whetham L; Gul X; Al-Kobati E; Gorter AC
    Glob Health Sci Pract; 2016 Aug; 4 Suppl 2(Suppl 2):S94-S108. PubMed ID: 27540129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Creating conditions for greater private sector participation in achieving contraceptive security.
    Sharma S; Dayaratna V
    Health Policy; 2005 Mar; 71(3):347-57. PubMed ID: 15694501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Public- and private-sector partnerships in contraceptive research and development: guiding principles.
    Brooke S; Vail JG
    Int J Gynaecol Obstet; 1999 Dec; 67 Suppl 2():S125-39. PubMed ID: 10661750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new model for collaboration: the alliance for microbicide development.
    Harrison PF
    Int J Gynaecol Obstet; 1999 Dec; 67 Suppl 2():S39-53. PubMed ID: 10661740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hearing focuses on price of Norplant; Wyeth pledges discount for public sector.
    Wash Memo Alan Guttmacher Inst; 1993 Nov; (18):3-4. PubMed ID: 12318533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.